1. Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination. (15th December 2020) Authors: López-Medina, Eduardo; Biswal, Shibadas; Saez-Llorens, Xavier; Borja-Tabora, Charissa; Bravo, Lulu; Sirivichayakul, Chukiat; Vargas, Luis Martinez; Alera, Maria Theresa; Velásquez, Hector; Reynales, Humberto; Rivera, Luis; Watanaveeradej, Veerachai; Rodriguez-Arenales, Edith Johana; Yu, Delia; Es... Journal: Journal of infectious diseases Issue: Volume 225:Number 9(2022) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial. Issue 10234 (2nd May 2020) Authors: Biswal, Shibadas; Borja-Tabora, Charissa; Martinez Vargas, Luis; Velásquez, Hector; Theresa Alera, Maria; Sierra, Victor; Johana Rodriguez-Arenales, Edith; Yu, Delia; Wickramasinghe, V Pujitha; Duarte Moreira, Edson; Fernando, Asvini D; Gunasekera, Dulanie; Kosalaraksa, Pope; Espinoza, Felix; Lóp... Journal: Lancet Issue: Volume 395:Issue 10234(2020) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study. Issue 2 (February 2018) Authors: Sáez-Llorens, Xavier; Tricou, Vianney; Yu, Delia; Rivera, Luis; Jimeno, José; Villarreal, Ana Cecilia; Dato, Epiphany; Mazara, Sonia; Vargas, Maria; Brose, Manja; Rauscher, Martina; Tuboi, Suely; Borkowski, Astrid; Wallace, Derek Journal: Lancet infectious diseases Issue: Volume 18:Issue 2(2018) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial. Issue 10234 (2nd May 2020) Authors: Tricou, Vianney; Sáez-Llorens, Xavier; Yu, Delia; Rivera, Luis; Jimeno, José; Villarreal, Ana Cecilia; Dato, Epiphany; Saldaña de Suman, Onix; Montenegro, Nathali; DeAntonio, Rodrigo; Mazara, Sonia; Vargas, Maria; Mendoza, Debbie; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Tuboi, Suely; Bork... Journal: Lancet Issue: Volume 395:Issue 10234(2020) Page Start: 1434 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study. Issue 6 (June 2017) Authors: Sáez-Llorens, Xavier; Tricou, Vianney; Yu, Delia; Rivera, Luis; Tuboi, Suely; Garbes, Pedro; Borkowski, Astrid; Wallace, Derek Journal: Lancet infectious diseases Issue: Volume 17:Issue 6(2017:Jun.) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003). (4th October 2021) Authors: Rivera, Luis; Biswal, Shibadas; Sáez-Llorens, Xavier; Reynales, Humberto; López-Medina, Eduardo; Borja-Tabora, Charissa; Bravo, Lulu; Sirivichayakul, Chukiat; Kosalaraksa, Pope; Martinez Vargas, Luis; Yu, Delia; Watanaveeradej, Veerachai; Espinoza, Felix; Dietze, Reynaldo; Fernando, LakKumar; Wic... Journal: Clinical infectious diseases Issue: Volume 75:Number 1(2022) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗